Monoamine oxidase activities in human cystic and colonic arteries - Influence of age

Journal of Neural Transmission, Supplement

Volumn , Issue 52, 1998, Pages 217-223

  Figueiredo, I V ^a   Martinez Coscolla, A ^b   Cotrim, M D ^a   Caramona, M M ^a   Callingham, B A ^b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; BENZYLAMINE; CATECHOLAMINE; PHENETHYLAMINE; SEROTONIN; AMINE OXIDASE (COPPER CONTAINING);

ADULT; AGED; ARTERY; ARTICLE; COLON; DEAMINATION; ENZYME KINETICS; FEMALE; HUMAN; HUMAN TISSUE; INNERVATION; MALE; PRIORITY JOURNAL; AGE; AGING; ENZYMOLOGY; GALLBLADDER; GROWTH, DEVELOPMENT AND AGING; KINETICS; METABOLISM; MIDDLE AGED; SEXUAL DEVELOPMENT; VASCULARIZATION;

AGE FACTORS; AGED; AGING; AMINE OXIDASE (COPPER-CONTAINING); ARTERIES; COLON; FEMALE; GALLBLADDER; HUMANS; KINETICS; MALE; MIDDLE AGED; MONOAMINE OXIDASE; SEX CHARACTERISTICS;

EID: 0031900324     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6499-0_20     Document Type: Article

References (26)

1. Banchelli G, Buffoni F, Elliott J, Callingham BA (1990) A study of the biochemical pharmacology of 3,5-ethoxy-4-aminomethylpyiridine (B24), a novel amine oxidase inhibitor with selectivity for tissue bound semicarbazide-sensitive amine oxidase enzymes. Neurochem Int 17: 215-221
2. Branco D, Caramona MM, Martel F, Ferreira de Almeida JA, Osswald W (1992) Predominance of oxidative deamination in the metabolism of exogenous noradrenaline by the normal and chemically denervated human uterine artery. Naunyn Schmiedebergs Arch Pharmacol 346: 286-293
3. Buffoni F (1993) Properties, distribution and physiological role of semicarbazide-sensitive amine oxidase. Curr Topics Pharmacol 2: 33-50
4. Cabrita AMS (1986) A imunocitoquímica no estudo das lesões neoplásicas. Arq Patol Geral Anat Patol Univ Coimbra Vol XX (Nova série): 97-104
5. Callingham BA (1983) Comparative aspects of monoamine oxidase. Vet Res Commun 7: 325-330
6. Callingham BA (1986) Some aspects of monoamine oxidase pharmacology. Cell Biochem Funct 4:99-108
7. Callingham BA, Barrand MA (1987) Some properties of semicarbazide-sensitive amine oxidases. J Neural Transm [Suppl] 23: 37-54
8. Caramona MM (1982) Monoamine oxidase of types A and B in the saphenous vein and mesenteric artery of the dog. Naunyn Schmiedebergs Arch Pharmacol 319: 121-124
9. Elliot J, Callingham BA, Sharman DF (1989) Semicarbazide-sensitive amine oxidase (SSAO) on rat aorta: interactions with some naturally occurring substrates and their structural analogues. Biochem Pharmacol 38: 1507-1515
10. Elliot J, Callingham BA, Sharman DF (1991) Amine oxidase enzymes of sheep blood vessels and blood plasma: a comparison of their properties. Comp Biochem Physiol 102: 83-89
11. Figueiredo IV, Caramona MM, Cotrim MD, Fontes Ribeiro CA, Macedo TRA, Pereira J, Silveira L, Falcão F (1995) The activity of semicarbazide sensitive amine oxidase in human uterine arteries. Pharmacol Res 31 [Suppl]: 240
12. Fowler CJ, Callingham BA (1978) Monoamine oxidase A and B: a useful concept? Biochem Pharmacol 27: 97-101
13. Hall DWR, Logan BW, Parsons GH (1969) Further studies on the inhibition of monoamine oxidase by M & B 9302 (clorgyline). I. Substrate specificity in various mammalian species. Biochem Pharmacol 18: 1447-1454
14. Johnston (1968) Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol 17: 1285-1297
15. Kopin IJ (1985) Catecholamines metabolism: basic aspects and clinical significance. Pharmacol Rev 37: 333-364
16. Lewinshon R (1984) Mammaliam monoamine-oxidising enzymes, with special references to benzylamine oxidase in human tissues. Braz J Med Biol Res 17: 223-256
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275
18. Lyles GA, Fitzpatrick CMS (1985) An allylamine derivative (MDL 72145) with potent irreversible inhibitory actions on rat aorta semicarbazide-sensitive amine oxidase. J Pharm Pharmacol 37: 29-335
19. Osswald W (1988) Disposition of catecholamines blood vessel wall. In: Bevan JA, Majewski H, Maxwell RA, Story DF (eds) Vascular neuroeffector mechanisms. IRL Press, Oxford, pp 321-329
20. Osswald W, Guimaraes S (1983) Adrenergic mechanisms in blood vessels: morphological and pharmacological aspects. Rev Physiol Biochem Pharmacol 96: 53-122
21. Rode J, Dhillon AP (1984) Neuron specific enolase and S100 protein as possible prognostic indicators in melanoma. Histopath 8: 1041-1052
22. Schurr A (1982) Monoamine oxidase: to B or not to B? Life Sci 30: 1059-1063
23. Warnhoff M (1984) Simultaneous determination of Ne, dopamine, 5-HT and their main metabolits in rat brain using "HPLC-EC". J Chrom 307: 271-281
24. Wilkinson GN (1961) Statistical estimations in enzyme kinetic. Biocem J 80: 324-332
25. Yang HYT, Neff NH (1973) β-phenylethylamine, a specific substrate for type B monoamine oxidase of brain. J Pharmacol Exp Ther 187: 365-371
26. Youdim MBH, Finberg JPM, Tipton KF (1988) Monoamine oxidase. In: Trendelenburg U, Weiner N (eds) Catecholamines, vol I. Springer, Berlin Heidelberg New York Tokyo, pp 119-192